{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:21:18Z","timestamp":1793118078833,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:00:00Z","timestamp":1760745600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016394","name":"Ludwig Center at Harvard","doi-asserted-by":"publisher","award":["5R01AA020744"],"award-info":[{"award-number":["5R01AA020744"]}],"id":[{"id":"10.13039\/100016394","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["5R01AA020744"],"award-info":[{"award-number":["5R01AA020744"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35 CA232105"],"award-info":[{"award-number":["R35 CA232105"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.omtn.2025.102752","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T07:31:09Z","timestamp":1761204669000},"page":"102752","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["MicroRNA-21 is a potential therapeutic agent targeting Tgfbi and mitigating high-fat-diet-induced liver disease and cancer"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2438-7003","authenticated-orcid":false,"given":"Urmila","family":"Jagtap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anan","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuho","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylie A.","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei","family":"Manakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyongyi","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imad","family":"Nasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8263-0409","authenticated-orcid":false,"given":"Frank J.","family":"Slack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2025.102752_bib1","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.cgh.2023.04.015","article-title":"The Global Burden of Liver Disease","volume":"21","author":"Younossi","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.omtn.2025.102752_bib2","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.omtn.2025.102752_bib3","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multi-society Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.omtn.2025.102752_bib4","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.omtn.2025.102752_bib5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-021-00565-8","article-title":"Natural history of NAFLD: knowns and unknowns","volume":"19","author":"Tsochatzis","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.omtn.2025.102752_bib6","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1053\/j.gastro.2016.01.037","article-title":"Genetic Factors That Affect Risk of Alcoholic and Nonalcoholic Fatty Liver Disease","volume":"150","author":"Anstee","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.omtn.2025.102752_bib7","article-title":"Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.omtn.2025.102752_bib8","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jcmgh.2018.10.016","article-title":"Resolving the Paradox of Hepatic Insulin Resistance","volume":"7","author":"Santoleri","year":"2019","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.omtn.2025.102752_bib9","first-page":"536","article-title":"Obesity and the Western Diet: How We Got Here","volume":"117","author":"Rakhra","year":"2020","journal-title":"Mo. Med."},{"key":"10.1016\/j.omtn.2025.102752_bib10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12876-016-0477-5","article-title":"Development of a novel mouse model of hepatocellular carcinoma with nonalcoholic steatohepatitis using a high-fat, choline-deficient diet and intraperitoneal injection of diethylnitrosamine","volume":"16","author":"Kishida","year":"2016","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.omtn.2025.102752_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109199","article-title":"High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms","volume":"330","author":"Lian","year":"2020","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.omtn.2025.102752_bib12","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.omtn.2025.102752_bib13","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1007\/s10620-015-4002-4","article-title":"Role of MicroRNAs in NAFLD\/NASH","volume":"61","author":"Szabo","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.omtn.2025.102752_bib14","doi-asserted-by":"crossref","first-page":"706","DOI":"10.4161\/rna.8.5.16154","article-title":"Regulation and function of miRNA-21 in health and disease","volume":"8","author":"Kumarswamy","year":"2011","journal-title":"RNA Biol."},{"key":"10.1016\/j.omtn.2025.102752_bib15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fmed.2020.00007","article-title":"Critical Role of microRNA-21 in the Pathogenesis of Liver Diseases","volume":"7","author":"Zhang","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.omtn.2025.102752_bib16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cca.2013.05.021","article-title":"Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver","volume":"424","author":"Yamada","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.omtn.2025.102752_bib17","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.2217\/bmm-2018-0096","article-title":"Clinical significance of microRNA-21 expression in disease progression of patients with hepatocellular carcinoma","volume":"12","author":"Yoon","year":"2018","journal-title":"Biomark. Med."},{"key":"10.1016\/j.omtn.2025.102752_bib18","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3892\/ijmm.2015.2076","article-title":"miR-21 regulates triglyceride and cholesterol metabolism in non-alcoholic fatty liver disease by targeting HMGCR","volume":"35","author":"Sun","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.omtn.2025.102752_bib19","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.4049\/jimmunol.2001039","article-title":"Context-Dependent miR-21 Regulation of TLR7-Mediated Autoimmune and Foreign Antigen-Driven Antibody-Forming Cell and Germinal Center Responses","volume":"206","author":"Schell","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.omtn.2025.102752_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fimmu.2015.00019","article-title":"Turning 21: Induction of miR-21 as a Key Switch in the Inflammatory Response","volume":"6","author":"Sheedy","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2025.102752_bib21","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3892\/br.2016.747","article-title":"Emerging role of microRNA-21 in cancer","volume":"5","author":"Feng","year":"2016","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.omtn.2025.102752_bib22","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1111\/liv.15682","article-title":"miR-21-5p promotes NASH-related hepatocarcinogenesis","volume":"43","author":"Rodrigues","year":"2023","journal-title":"Liver Int."},{"key":"10.1016\/j.omtn.2025.102752_bib23","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1136\/gutjnl-2014-308430","article-title":"MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway","volume":"65","author":"Wu","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.omtn.2025.102752_bib24","first-page":"1660","article-title":"miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma","volume":"27","author":"Zhu","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.omtn.2025.102752_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101581","article-title":"MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectives","volume":"65","author":"Hochreuter","year":"2022","journal-title":"Mol. Metab."},{"key":"10.1016\/j.omtn.2025.102752_bib26","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3892\/mmr.2021.12463","article-title":"PPAR\u03b3 attenuates hepatic inflammation and oxidative stress of non-alcoholic steatohepatitis via modulating the miR-21-5p\/SFRP5 pathway","volume":"24","author":"Zhang","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.omtn.2025.102752_bib27","article-title":"miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice","volume":"8","author":"Rodrigues","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omtn.2025.102752_bib28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.toxlet.2016.06.012","article-title":"MicroRNA-21 is associated with fibrosis in a rat model of nonalcoholic steatohepatitis and serves as a plasma biomarker for fibrotic liver disease","volume":"258","author":"Takeuchi-Yorimoto","year":"2016","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.omtn.2025.102752_bib29","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1136\/gutjnl-2015-310822","article-title":"Stress-activated miR-21\/miR-21\u2217 in hepatocytes promotes lipid and glucose metabolic disorders associated with high-fat diet consumption","volume":"65","author":"Calo","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.omtn.2025.102752_bib30","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1136\/gutjnl-2014-308883","article-title":"Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPAR\u03b1 expression","volume":"65","author":"Loyer","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.omtn.2025.102752_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13194983","article-title":"Mir-21 Suppression Promotes Mouse Hepatocarcinogenesis","volume":"13","author":"Correia de Sousa","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.omtn.2025.102752_bib32","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.omtn.2021.06.019","article-title":"miR-21 mimic blocks obesity in mice: A novel therapeutic option","volume":"26","author":"Lhamyani","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2025.102752_bib33","doi-asserted-by":"crossref","first-page":"44050","DOI":"10.18632\/oncotarget.17211","article-title":"Circulating miR-21 serves as a serum biomarker for hepatocellular carcinoma and correlated with distant metastasis","volume":"8","author":"Guo","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.omtn.2025.102752_bib34","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/mc.21864","article-title":"Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance","volume":"52","author":"Karakatsanis","year":"2013","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.omtn.2025.102752_bib35","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41592-019-0422-y","article-title":"CancerMine: a literature-mined resource for drivers, oncogenes and tumor suppressors in cancer","volume":"16","author":"Lever","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtn.2025.102752_bib36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1440-1746.2011.07007.x","article-title":"Retinoic acids and hepatic stellate cells in liver disease","volume":"27","author":"Lee","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.omtn.2025.102752_bib37","article-title":"Retinoids in health and disease: A role for hepatic stellate cells in affecting retinoid levels","volume":"1865","author":"Haaker","year":"2020","journal-title":"Biochim. Biophys. Acta. Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.omtn.2025.102752_bib38","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1194\/jlr.M029801","article-title":"Hepatic retinoid stores are required for normal liver regeneration","volume":"54","author":"Shmarakov","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.omtn.2025.102752_bib39","article-title":"The Role of Lipophagy in the Development and Treatment of Non-Alcoholic Fatty Liver Disease","volume":"11","author":"Grefhorst","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.omtn.2025.102752_bib40","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1056\/NEJMra2304578","article-title":"Physiological Integration of Taste and Metabolism","volume":"390","author":"Egan","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2025.102752_bib41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/0148607115617438","article-title":"Proceedings of the 2015 ASPEN Research Workshop-Taste Signaling","volume":"41","author":"Spector","year":"2017","journal-title":"J. Parenter. Enteral Nutr."},{"key":"10.1016\/j.omtn.2025.102752_bib42","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1113\/jphysiol.2006.108506","article-title":"Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders","volume":"574","author":"Viollet","year":"2006","journal-title":"J. Physiol."},{"key":"10.1016\/j.omtn.2025.102752_bib43","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1053\/j.gastro.2012.06.004","article-title":"A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches","volume":"143","author":"Seki","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.omtn.2025.102752_bib44","article-title":"Scalable and deep profiling of mRNA targets for individual microRNAs with chimeric eCLIP","author":"Manakov","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.omtn.2025.102752_bib45","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.05005","article-title":"Predicting effective microRNA target sites in mammalian mRNAs","volume":"4","author":"Agarwal","year":"2015","journal-title":"eLife"},{"key":"10.1016\/j.omtn.2025.102752_bib46","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jgg.2021.07.007","article-title":"EVenn: Easy to create repeatable and editable Venn diagrams and Venn networks online","volume":"48","author":"Chen","year":"2021","journal-title":"J. Genet. Genomics"},{"key":"10.1016\/j.omtn.2025.102752_bib47","doi-asserted-by":"crossref","first-page":"10461","DOI":"10.3390\/ijms130810461","article-title":"Transforming growth Factor-Beta-Induced Protein (TGFBI)\/(\u03b2ig-H3): a matrix protein with dual functions in ovarian cancer","volume":"13","author":"Ween","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2025.102752_bib48","doi-asserted-by":"crossref","first-page":"D1334","DOI":"10.1093\/nar\/gkab970","article-title":"OncoDB: an interactive online database for analysis of gene expression and viral infection in cancer","volume":"50","author":"Tang","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2025.102752_bib49","first-page":"4655","article-title":"miR-21-5p induces cell proliferation by targeting TGFBI in non-small cell lung cancer cells","volume":"16","author":"Yan","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.omtn.2025.102752_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2022.170842","article-title":"Transforming growth factor-\u03b2 induced protein regulates pulmonary fibrosis via the G-protein signaling modulator 2\/Snail axis","volume":"155","author":"Yang","year":"2022","journal-title":"Peptides (N.Y.)"},{"key":"10.1016\/j.omtn.2025.102752_bib51","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.05607","article-title":"The genetic architecture of NAFLD among inbred strains of mice","volume":"4","author":"Hui","year":"2015","journal-title":"eLife"},{"key":"10.1016\/j.omtn.2025.102752_bib52","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cels.2017.12.006","article-title":"Integration of Multi-omics Data from Mouse Diversity Panel Highlights Mitochondrial Dysfunction in Non-alcoholic Fatty Liver Disease","volume":"6","author":"Chella Krishnan","year":"2018","journal-title":"Cell Syst."},{"key":"10.1016\/j.omtn.2025.102752_bib53","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221738","article-title":"The genetic background shapes the susceptibility to mitochondrial dysfunction and NASH progression","volume":"220","author":"Benegiamo","year":"2023","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.omtn.2025.102752_bib54","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1038\/s41598-023-32037-1","article-title":"Mouse strain-dependent variation in metabolic associated fatty liver disease (MAFLD): a comprehensive resource tool for pre-clinical studies","volume":"13","author":"Karimkhanloo","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2025.102752_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155163","article-title":"Susceptibility of Different Mouse Wild Type Strains to Develop Diet-Induced NAFLD\/AFLD-Associated Liver Disease","volume":"11","author":"Fengler","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2025.102752_bib56","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jhep.2016.05.005","article-title":"A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer","volume":"65","author":"Asgharpour","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.omtn.2025.102752_bib57","article-title":"An update on animal models of liver fibrosis","volume":"10","author":"Wu","year":"2023","journal-title":"Front. Med."},{"key":"10.1016\/j.omtn.2025.102752_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0959-9673.2006.00465.x","article-title":"Mouse models in non-alcoholic fatty liver disease and steatohepatitis research","volume":"87","author":"Anstee","year":"2006","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.omtn.2025.102752_bib59","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/0023677215570078","article-title":"Mouse models of metabolic liver injury","volume":"49","author":"Ramadori","year":"2015","journal-title":"Lab. Anim."},{"key":"10.1016\/j.omtn.2025.102752_bib60","article-title":"Mouse Models of Hepatocellular Carcinoma: Classification, Advancement, and Application","volume":"12","author":"Liu","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omtn.2025.102752_bib61","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/0023677215570086","article-title":"Diethylnitrosamine (DEN)-induced carcinogenic liver injury in mice","volume":"49","author":"Tolba","year":"2015","journal-title":"Lab. Anim."},{"key":"10.1016\/j.omtn.2025.102752_bib62","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.3748\/wjg.v18.i11.1141","article-title":"Genetically modified mouse models for the study of nonalcoholic fatty liver disease","volume":"18","author":"Nagarajan","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.omtn.2025.102752_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.745649","article-title":"Pan-Cancer Analysis of the Associations of TGFBI Expression With Prognosis and Immune Characteristics","volume":"8","author":"Chen","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.omtn.2025.102752_bib64","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12943-015-0335-z","article-title":"The role of TGFBI (\u03b2ig-H3) in gastrointestinal tract tumorigenesis","volume":"14","author":"Han","year":"2015","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.omtn.2025.102752_bib65","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/s12276-023-00947-9","article-title":"TGFBI remodels adipose metabolism by regulating the Notch-1 signaling pathway","volume":"55","author":"Lee","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.omtn.2025.102752_bib66","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1093\/nar\/gkp117","article-title":"Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells","volume":"37","author":"Wickramasinghe","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2025.102752_bib67","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqac002","article-title":"Unexplored Functions of Sex Hormones in Glioblastoma Cancer Stem Cells","volume":"163","author":"Lee","year":"2022","journal-title":"Endocrinology"},{"key":"10.1016\/j.omtn.2025.102752_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115922","article-title":"Establishment of a general NAFLD scoring system for rodent models and comparison to human liver pathology","volume":"9","author":"Liang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2025.102752_bib69","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253125003063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253125003063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T09:56:08Z","timestamp":1778838968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253125003063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2162253125003063"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2025.102752","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNA-21 is a potential therapeutic agent targeting Tgfbi and mitigating high-fat-diet-induced liver disease and cancer","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2025.102752","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102752"}}